Screener / SEC EDGAR /CIK 0001832466 /10-K filed Feb 27, 2026, compared with Feb 27, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Financials · Health Insurance

Alignment Healthcare, Inc. ALHC

Compare with peers Embed
The 10-K against last year's

149 changes: 24 added, 41 removed, 75 reworded, 9 quiet changes

10-K Feb 27, 2026 vs Feb 27, 2025

10-K 0001628280-26-012545 (Feb 27, 2026) vs 10-K 0001628280-25-008730 (Feb 27, 2025)

Every paragraph, and how much of it changed

One bar per paragraph, in the order of the 10-K. Height and colour show the share of its words not in the closest paragraph a year earlier; the tallest bars are new paragraphs.

Risk Factors

361 paragraphs · 20 new · 73 reworded · 28 gone · 10-K Feb 27, 2026 against Feb 27, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 126 · 50% changed Every version of it
•CMS uses a risk-adjustment model which adjusts premiums paid to Medicare Advantage organizations according to the health status of covered members. The risk-adjustment model, which CMS implemented pursuant to the Balanced Budget Act of 1997 and the Benefits Improvement and Protection Act of 2000 (“BIPA”), generally pays more where a plan’s membership has higher expected costs. Under this model, amounts paid to Medicare Advantage organizations are based, in part, on actuarially determined bids, which include a process whereby our prospective payments are based on our estimated cost of providing standard Medicare-covered benefits to an enrollee with a “national average risk profile.” That baseline payment amount is adjusted to reflect the health status of our enrolled membership. Under the risk-adjustment methodology, all Medicare Advantage organizations must collect and submit the data from hospital inpatient, hospital outpatient, and physician services to CMS within prescribed deadlines. The CMS risk-adjustment model uses the diagnosis data to calculate the risk-adjusted premium payment to Medicare Advantage organizations, which CMS adjusts for coding pattern differences between the health plans and the government fee-for-service program. In certain cases, we rely on providers, including certain providers in our network who are our employees, to code their claim submissions with appropriate diagnoses, which we send to CMS as the basis for our payment received from CMS under the actuarial risk-adjustment model. We also rely on these providers to document appropriately all medical data, including the diagnosis data submitted with claims, and we rely on our technology platform to aggregate, organize, interpret and report such data. In addition, we conduct medical record reviews as part of our data and payment accuracy compliance efforts, to more accurately reflect diagnosis conditions under the risk adjustment model. These compliance efforts include the internal contract level audits described in more detail below, as well as ordinary course reviews of our internal business processes.
Paragraph 271 · 50% changed Every version of it
The policies and decisions of the federal and state governments regarding the Medicare Advantage program in which we participate have a substantial impact on our profitability. These governmental policies and decisions, which we cannot predict with certainty, directly shape the revenues given to us under the Medicare Advantage program, the eligibility and enrollment of our members, the services we provide to our members, and our administrative, healthcare services, and other costs associated with the Medicare Advantage program. Legislative or regulatory actions, such as changes to the Medicare Advantage program, those resulting in a reduction in payments to us, an increase in our cost of administrative and healthcare services, or additional fees, taxes or assessments, may have a material adverse effect on our results of operations, financial position, and cash flows. For example, Additionally, CMS recently finalized new regulations requiring Utilization Management (UM) committees to include a health equity expert and conduct an annual analysis of prior authorization impacts on enrollees with social risk factors, with the findings publicly posted on their website. These changes expand upon recently imposed requirements for UM committees and the annual review of UM policies, further increasing the regulatory burden on MA plans. Additionally, CMS implemented stricter regulations on Third-Party Marketing Organizations (TPMOs), prohibiting the sharing or resale of personal beneficiary data without prior written consent, which may limit outreach efforts and reduce lead generation and enrollment opportunities for MA plans. CMS also finalized changes to the compensation structure for Medicare Advantage agents and brokers that were intended to reclassify certain administrative fees as compensation subject to CMS caps and restrict contractual terms that CMS viewed as potentially steering beneficiaries toward particular plans. In August 2025, a federal district court vacated these provisions, concluding that CMS exceeded its statutory authority and that aspects of the rulemaking were arbitrary and capricious. While this outcome preserves flexibility in agent and broker arrangements, it also creates uncertainty, as CMS may pursue future rulemaking in this area. CMS’s focus on marketing activities coincides with an apparent increased DOJ interest, as well. In recent years, the DOJ has launched investigations into whether marketing and recruiting practices of Medicare Advantage Organizations and their downstream providers violate the FCA.
Paragraph 270 · 43% changed Every version of it
The policies and decisions of the federal and state governments regarding the Medicare Advantage program in which we participate have a substantial impact on our profitability. These governmental policies and decisions, which we cannot predict with certainty, directly shape the revenues given to us under the Medicare Advantage program, the eligibility and enrollment of our members, the services we provide to our members, and our administrative, healthcare services, and other costs associated with the Medicare Advantage program. Legislative or regulatory actions, such as changes to the Medicare Advantage program, those resulting in a reduction in payments to us, an increase in our cost of administrative and healthcare services, or additional fees, taxes or assessments, may have a material adverse effect on our results of operations, financial position, and cash flows. For example, under the Contract Year 2026 Medicare Advantage and Part D final rule, CMS recently finalized new regulations requiring Utilization Management (UM) committees to include a health equity expert and conduct an annual analysis of prior authorization impacts on enrollees with social risk factors, with the findings publicly posted on their website. These changes expand upon recently imposed federal requirements for UM committees certain D-SNPs that, beginning in 2027, will require the use of integrated member identification cards that serve as the ID cards for both the Medicare and Medicaid plans in which an enrollee is enrolled, and the annual review completion of UM policies, further increasing an integrated health risk assessment for Medicare and Medicaid, rather than separate assessments for each program. CMS also codified timeframes for all special needs plans to conduct health risk assessments and develop individualized care plans, and to prioritize the regulatory burden on MA involvement of the enrollee or the enrollee’s representative in the development of such care plans. Additionally, CMS implemented stricter regulations on Third-Party Marketing Organizations (TPMOs), prohibiting the sharing These requirements may increase administrative complexity, operational costs, and coordination obligations for D-SNPs and may affect our ability to offer or resale of personal beneficiary data without prior written consent, which may limit outreach efforts and reduce lead generation and enrollment opportunities for MA plans. CMS’s focus on marketing activities coincides with an apparent increased DOJ interest, as well. In recent years, the DOJ has launched investigations into whether marketing and recruiting practices of Medicare Advantage Organizations and their downstream providers violate the FCA. maintain such plans in certain markets.
Paragraph 246 · 43% changed Every version of it
We, our in-house and externally engaged physicians and the facilities in which they operate are subject to various federal, state and local licensing and certification laws and regulations and accreditation standards and other laws, relating to, among other things, the adequacy of medical care, equipment, privacy of member information, physician relationships, personnel and operating policies and procedures. Failure to comply with these licensing, certification and accreditation laws, regulations and standards could result in prior payments being subject to recoupment, requirements to make significant changes to our operations and can give rise to civil or, in extreme cases, criminal penalties. We routinely take the steps we believe are necessary to retain or obtain all requisite licensure and operating authorities. While we have made reasonable efforts to substantially comply with federal, state and local licensing and certification laws and regulations and standards as we interpret them, the agencies that administer these programs may find that we have failed to comply in some material respects. If this were to occur, we could be subject to civil and/or criminal penalties, or we could be required to close or limit our operations at relevant sites.
Paragraph 90 · 42% changed Every version of it
In addition, audits of our performance for past or future periods may result in downgrades to our Star ratings. For example, if a CMS audit finds that a particular issue of noncompliance impacts the data source for a Star measure, the Star measure may be reduced if the data set is deemed inaccurate or biased. Accordingly, our plans may receive a lower Star rating and may not be eligible for full level quality bonus payments, which could adversely affect the benefits we can offer, reduce membership and/or reduce profit margins. Also, CMS has the authority to terminate contracts that have had a rating of less than three Stars for three consecutive years, whereas Medicare Advantage plans with five Stars are permitted to conduct enrollment throughout almost the entire year. Because low quality ratings can potentially lead to the termination of one or more of our contracts we may not be able to prevent the potential termination of a plan or a shift of members to other plans based upon quality issues, which could, in turn, have a material adverse effect on our business, results of operations, financial condition and cash flows.
Paragraph 236 · 39% changed Every version of it
The On September 23, 2025, the CPPA has released for public comment draft finalized its regulations on risk assessments, cybersecurity assessments, and automated decision-making technologies, which close on February 19, 2025. technologies. These regulations are the final components of the CPRA's amendments to the CCPA, which granted the CPPA the authority to pass additional regulations. These regulations in their draft form contain substantial new compliance obligations with respect to PII we process.
Paragraph 341 · 37% changed Every version of it
•establish advance notice requirements for nominations for elections to our Board or for proposing matters that can be acted upon by stockholders at stockholder meetings, provided, however, that at any time the Lead Sponsor beneficially own, in the aggregate, at least 40% of our common stock then outstanding, such advance notice provision will not apply to the Lead Sponsor. meetings.
Paragraph 254 · 34% changed Every version of it
Many states also have enacted laws similar in scope and purpose to the Anti-Kickback Statute and, in more limited instances, the Stark Law, that are not limited to services for which Medicare or Medicaid payment is made. In addition, most states have statutes, regulations, or professional codes that restrict a physician from accepting various kinds of remuneration in exchange for making referrals. These laws vary from state to state and have seldom been interpreted by the courts or regulatory agencies. In states that have enacted these statutes, we believe that regulatory authorities and state courts interpreting these statutes may regard federal law under the Anti-Kickback Statute and the Stark Law as persuasive.

MD&A

102 paragraphs · 4 new · 40 reworded · 13 gone · 10-K Feb 27, 2026 against Feb 27, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 76 · 41% changed
For the year ended December 31, 2024, 2025, net cash provided by operating activities was $34.8 $139.9 million, an increase of $94.0 $105.2 million compared to net cash used in provided by operating activities of $59.2 $34.8 million for the year ended December 31, 2023. 2024. The increase is mainly attributable to an increase in membership and reduction of net loss, an increase in medical expenses payable as a result of the increased Health Plan membership growth during the year ended December 31, 2024 compared expense payables related to the year ended December 31, 2023, as well as timing of our payments, and changes to the Part D program related to the Inflation Reduction Act. This increase was partially offset by an increase in prepaid expenses and other current assets due to a decrease change in our net loss over Part D balances arising from the same period. Inflation Reduction Act.
Paragraph 39 · 36% changed
Our capitation revenue consists primarily We also participate in the CMS “ACO Realizing Equity, Access, and Community Health Model” or “ACO REACH” model, formerly the Direct Contracting Model ("DCE"). CMS serves as the claim adjudicator for institutional and specialists care, and directly pays for such fee for service claims. The ACO REACH entity ("ACO") is responsible for the cost of capitated fees for medical health care services provided by us under arrangements with our third-party payors and from CMS related to our the patient population attributed to the ACO REACH entity. by participating in 100% savings/losses via the risk share model and in some cases, are financially responsible for the supplemental benefits provided to the patients. In 2024, we entered into a management services and risk management agreement with a third-party healthcare company. The third-party is responsible for arranging and controlling the health care services provided to the ACO members, and for providing certain management and support services with respect to ACO operations. The third-party also assumes specified upside and downside financial risk risks relative to the ACO’s performance. As a result of this arrangement, revenue is recorded on a net basis within other revenue on the consolidated statement of operations for the year years ended December 31, 2025 and 2024. On July 30, 2025, we notified CMS that we will discontinue our participation in the ACO REACH model as of December 31, 2025. We expect this to have an immaterial impact to our financial results.
Paragraph 78 · 33% changed
For the year ended December 31, 2024, 2025, net cash provided by financing activities was $156.0 $18.0 million, an increase a decrease of $155.9 $138.0 million compared to net cash provided by financing activities of $0.1 $156.0 million for the year ended December 31, 2023. 2024. The increase in net cash provided by financing activities decrease is mainly primarily attributable to cash received of $330.0 million in connection with the issuance of the convertible notes discussed above, as well as note refinance and the $50.0 million draw down of the Oxford Delayed Draw term loan in June that occurred during the year ended December 31, 2024. This decrease was offset by $18.1 million in proceeds from the repayment exercise of $215.0 million related to the Oxford term loans, as discussed above. stock options.
Paragraph 57 · 33% changed
Interest expense. Interest expense was $23.5 $15.8 million and $21.2 $23.5 million for the years ended December 31, 2024 2025 and 2023, 2024, respectively, an increase a decrease of $2.3 $7.7 million or 10.8%. 32.8%. The increase decrease in interest expense was partially due mainly attributable to an increase a decrease in the debt balance as a result of the $50.0 million drawdown of the Oxford Delayed Draw term loan in June 2024. Additionally, we experienced a higher interest rate on our debt balance during the majority of the year, which then decreased as a result of the issuance of the convertible notes and repayment of the Oxford term loan as discussed below. Prior to the repayment of the Oxford term loans, the average interest rate during 2024 was 11.77% compared to an average interest rate of 11.35% during the year ended December 31, 2023. following refinancing in November 2024. The convertible notes have an interest rate of 4.25%. 4.25%, compared to our prior term loans which had an average interest rate of 11.77% for the year ended December 31, 2024. The decrease in interest rate was offset by an increase in our average long-term debt balance which was $330.0 million for the year ended December 31, 2025 compared to an average balance of $247.5 million for the year ended December 31, 2024.
Paragraph 22 · 32% changed
(1) Includes (2)Amortization expense for the year ended December 31, 2025 includes $0.6 million in impairment expense related to the remeasurement of goodwill associated with one of our subsidiaries. Amortization expense for the year ended December 31, 2024 includes $0.6 million in impairment expense related to intangible assets that were written off during the year year.
Paragraph 29 · 32% changed
(1) Includes (1)Amortization expense for the year ended December 31, 2025 includes $0.6 million in impairment expense related to the remeasurement of goodwill associated with one of our subsidiaries. Amortization expense for the year ended December 31, 2024 includes $0.6 million in impairment expense related to intangible assets that were written off during the year year.
Paragraph 52 · 30% changed
Earned Premiums. Earned premium revenues were $2,671.9 $3,911.7 million and $1,800.9 $2,671.9 million for the years ended December 31, 2024 2025 and 2023, 2024, respectively, an increase of $871.0 $1,239.8 million or 48.4%. 46.4%. The increase was primarily driven by growth in our Health Plan membership, which increased 58.6% 25.0% between December 31, 2025 and December 31, 2024 and December 31, 2023. higher revenue per member per month. The increase was offset by a decrease in ACO REACH revenue due per member per month is primarily attributable to an increase in the change CMS benchmark rates and Part D revenue rates from gross to net revenue treatment. ACO REACH revenue decreased $125.2 million, or 101.0%, for changes arising from the year ended December 31, 2024 compared to the year ended December 31, 2023. Inflation Reduction Act.
Paragraph 63 · 30% changed
We believe that our liquid assets will be sufficient to fund our operating and organic capital needs for at least the next 12 months. Our assessment of the period of time through which our financial resources will be adequate to support our operations is a forward-looking statement and involves risks and uncertainties. Our actual results could vary because of, and our future capital requirements will depend on, many factors, including our growth rate, the timing and extent of spending to expand our presence in existing markets, expand into new markets, increase our sales and marketing activities and develop our technology. Additionally, in the future we may enter into arrangements to acquire or invest in complementary businesses, services and technologies, including intellectual property rights, which may also substantially increase our capital needs.

A paragraph is matched with the one last year that shares the most of its words; under half in common makes it new. The paragraphs shown are the 8 reworded the most in each section.

The paragraph that changed most in each section

The redline

Marked against last year's 10-K: cut words struck through, new words highlighted.

Risk Factors257 words changed in this paragraph; it is 33% similar to last year's version.
Currently, we are a holding company and do not have any material assets or operations other than ownership of equity interests of our subsidiaries. Our operations are conducted almost entirely through our subsidiaries, and our ability to generate cash to meet our obligations or to pay dividends is highly dependent on the earnings of, and receipt of funds from, our subsidiaries through dividends, administrative expenses or intercompany loans. The ability of our subsidiaries to generate sufficient cash flow from future operations to allow us and them to make scheduled payments on our obligations will depend on their future financial performance, which will be affected by a range of economic, competitive and business factors, many of which are outside of our control. We cannot assure you that the cash flow and future earnings of our operating subsidiaries will be adequate for our subsidiaries to service their debt obligations. If our subsidiaries do not generate sufficient cash flow from future operations to satisfy corporate obligations, we may have to: undertake alternative financing plans (such as refinancing), restructure debt, sell assets, reduce or delay capital investments, or seek to raise additional capital. We cannot assure you that any such alternative refinancing would be possible, that any assets could be sold, or, if sold, of the timing of the sales and the amount of proceeds realized from those sales, that additional financing could be obtained on acceptable terms, if at all, or that additional financing would be permitted under the terms of our various debt instruments then in effect. Our inability to generate sufficient cash flow to satisfy our obligations, or to refinance our obligations on commercially reasonable terms, would have an adverse effect on our business, financial condition and results of operations. Furthermore, we and our subsidiaries may incur substantial additional indebtedness in the future that may severely restrict or prohibit our subsidiaries from making distributions, paying dividends or making loans to us.

Source: Item 1A, 10-K 0001628280-26-012545 vs Item 1A, 10-K 0001628280-25-008730

MD&A169 words changed in this paragraph; it is 36% similar to last year's version.
Interest expense. Interest expense was $23.5 $15.8 million and $21.2 $23.5 million for the years ended December 31, 2024 2025 and 2023, 2024, respectively, an increase a decrease of $2.3 $7.7 million or 10.8%. 32.8%. The increase decrease in interest expense was partially due mainly attributable to an increase a decrease in the debt balance as a result of the $50.0 million drawdown of the Oxford Delayed Draw term loan in June 2024. Additionally, we experienced a higher interest rate on our debt balance during the majority of the year, which then decreased as a result of the issuance of the convertible notes and repayment of the Oxford term loan as discussed below. Prior to the repayment of the Oxford term loans, the average interest rate during 2024 was 11.77% compared to an average interest rate of 11.35% during the year ended December 31, 2023. following refinancing in November 2024. The convertible notes have an interest rate of 4.25%. 4.25%, compared to our prior term loans which had an average interest rate of 11.77% for the year ended December 31, 2024. The decrease in interest rate was offset by an increase in our average long-term debt balance which was $330.0 million for the year ended December 31, 2025 compared to an average balance of $247.5 million for the year ended December 31, 2024.

Source: Item 7, 10-K 0001628280-26-012545 vs Item 7, 10-K 0001628280-25-008730

Accounting Policies133 words changed in this paragraph; it is 38% similar to last year's version.
We develop estimates for medical expenses incurred but not yet paid (“IBNP”), which includes an estimate for claims incurred but not reported (“IBNR”) and a payable for adjudicated claims. IBNR is estimated using an actuarial process that is consistently applied and centrally controlled. Medical expenses payable also includes an estimate for the costs necessary to process unpaid claims at the end of each period. We estimate the IBNR liability using actuarial methods that are commonly used by health insurance actuaries and meet Actuarial Standards of Practice. These actuarial methods consider factors, such as cost trends and completion factors that are assessed based on historical data for payment patterns, product mix, seasonality, utilization of health care services, and other relevant factors. Each period, we re-examine previously established IBNR estimates based on actual claim submissions and other changes in facts and circumstances. As the IBNR estimates recorded in prior periods develop, we adjust the amount of the estimates and include the changes in estimates in medical expenses in the period in which the change is identified.

Source: Item 8, Note 2 – Summary of Significant Accounting Policies, 10-K 0001628280-26-012545 vs Item 8, Note 2 – Summary of Significant Accounting Policies, 10-K 0001628280-25-008730

Legal Proceedings71 words changed in this paragraph; it is 76% similar to last year's version.
On April 27, 2022, a former employee of the Company filed a purported class action lawsuit (Dabney v. Alignment Healthcare USA, LLC, Orange County Superior Court) alleging that the Company failed to provide hourly employees with required meal and rest breaks or pay such workers a premium equal to an hour of pay for missed meal or rest breaks. Discovery in the matter commenced on June 8, 2022. On September 2, 2022, the court granted a stay of proceedings and discovery in anticipation of mediation scheduled for August 2023. On August 15, 2023, the Company entered into a tentative settlement of the action in consideration of an aggregate payment of $913. As a result of the tentative settlement, the Company has accrued for a potential liability of $913 as of December 31, 2025 for this matter, which was recorded within accounts payable and accrued expenses on the consolidated balance sheet and selling, general and administrative expenses on the consolidated statement of operations. Subsequent to period end, the settlement was approved by the court and the Company made payment in January 2026.

Source: Item 3, via Note 14 – Commitments and Contingencies, 10-K 0001628280-26-012545 vs Item 3, via Note 14 – Commitments and Contingencies, 10-K 0001628280-25-008730

Sentences and paragraphs added, removed or reworded

Every change, by type

Sentences and paragraphs of ALHC's Risk Factors and MD&A, 10-K Feb 27, 2026 against 10-K Feb 27, 2025. Each links to the text at sec.gov.

Quiet changes are sentences kept from last year with one to four words changed, at least one of them a hedge, a modal or a qualifier (may, could, will, not, significant, material…). A year or date rolling forward is not counted.

The full word list

adverse, adversely, all, although, anticipate, anticipates, any, approximately, believe, believes, can, cannot, certain, could, expect, expects, generally, however, if, intend, intends, largely, likely, many, material, materially, may, might, most, must, never, no, not, possible, primarily, probable, should, significant, significantly, some, substantial, substantially, unlikely, will, would

AddedRisk Factors
•Our use of machine learning and artificial intelligence, including within our AVA platform, may introduce operational, regulatory and legal risks that could adversely affect our business, financial condition and results of operations.
Read it in 10-K Feb 27, 2026 at sec.gov
AddedRisk Factors
Our use of machine learning and artificial intelligence, including within our AVA platform, may introduce operational, regulatory and legal risks that could adversely affect our business, financial condition and results of operations.
Read it in 10-K Feb 27, 2026 at sec.gov
AddedRisk Factors
We use machine learning, artificial intelligence (“AI”) and other automated data-analysis technologies in certain aspects of our operations, including within AVA, which aggregates and analyzes member and provider information to generate insights, alerts and recommendations and to support risk adjustment, care management and other activities. AI models may produce inaccurate, incomplete, biased or non-reproducible outputs due to limitations in data quality, model design or changing data patterns, and certain methodologies may lack transparency or explainability. If AI-supported processes adversely affect clinical or operational activities, coding or documentation, risk adjustment, utilization management, quality measurement or member stratification, we could experience reduced revenue, increased medical costs, member harm, regulatory exposure or reputational damage. Our use of AI also increases risks relating to data governance, privacy, cybersecurity and third-party technology dependencies, including risks arising from aggregation and use of sensitive data.
Read it in 10-K Feb 27, 2026 at sec.gov
AddedRisk Factors
The legal and regulatory framework governing AI in healthcare and insurance is rapidly evolving. Federal agencies, including HHS and CMS, are developing policies and guidance regarding the governance and permissible uses of AI in healthcare programs, and federal executive actions and proposed or enacted state laws seek to regulate AI use in sensitive or regulated contexts. New or changing AI-related requirements or enforcement priorities could restrict permissible uses of AI in Medicare Advantage or other regulated activities, require additional governance, validation, documentation, transparency or reporting, or increase audit, overpayment, penalty or liability risks. If our AI governance or use practices are determined to be deficient or non-compliant, we could be subject to investigations, sanctions, contractual liability or other adverse consequences.
Read it in 10-K Feb 27, 2026 at sec.gov
AddedRisk Factors
This may increase administrative burdens for plans by requiring new payment tracking systems and risk management strategies. Finally, 2026 is the first year that CMS will implement negotiated prices on certain high-cost Part D drugs, and Part D plans must include these drugs on their formularies at the maximum fair price. These changes may significantly alter the plans that we offer and may adversely affect our business, results of operations and financial condition.
Read it in 10-K Feb 27, 2026 at sec.gov
AddedRisk Factors
Currently, we are a holding company and do not have any material assets or operations other than ownership of equity interests of our subsidiaries. Our operations are conducted almost entirely through our subsidiaries, and our ability to generate cash to meet our obligations or to pay dividends is highly dependent on the earnings of, and receipt of funds from, our subsidiaries through dividends,
Read it in 10-K Feb 27, 2026 at sec.gov
Show the other 65
AddedRisk Factors
The CCPA prompted the passage of “copycat” legislation in a number states. It also prompted passage of consumer privacy laws that protect consumer health data specifically, such as the Washington My Health My Data Act. These state laws generally exempt HIPAA regulated covered entities and business associates, PHI, and/or personal information collected in the context of employment and business-to-business relationships. However, this patchwork of state laws may still add additional complexity, variation in requirements, restrictions and potential legal risk, require additional investment of resources in compliance programs, impact strategies and the availability of previously useful data and could result in increased compliance costs and/or changes in business practices and policies.
Read it in 10-K Feb 27, 2026 at sec.gov
AddedRisk Factors
Additionally, we have entered into a senior secured revolving credit facility with various banks (the “Revolving Credit Facility”) in the principal amount of up to $200,000,000. Indebtedness under the Revolving Credit Facility bears interest at a variable rate based on (i) the prime rate announced by Citibank, (ii) the federal funds effective rate or (iii) the forward-looking Secured Overnight Financing Rate ("SOFR"), plus, in each case, an applicable margin based on a consolidated senior secured leverage ratio, as set forth in the credit
Read it in 10-K Feb 27, 2026 at sec.gov
AddedRisk Factors
Because the interest rate applicable to our Revolving Credit Facility is based on, at our option, the prime rate, federal funds effective rate or SOFR, it is therefore subject to increases in interest rates. Fluctuations in interest rates can increase borrowing costs. To the extent the interest rates applicable to the Revolving Credit Facility increase, our interest expense will increase, in which event we may have difficulties making interest payments and funding our other fixed costs, and our available cash flow for general corporate requirements may be adversely affected.
Read it in 10-K Feb 27, 2026 at sec.gov
RemovedRisk Factors
We have incurred net losses on an annual basis since our inception, including a net loss of $128.1 million and $148.2 million for the years ended December 31, 2024 and December 31, 2023. As of December 31, 2024, we had an accumulated deficit of $1,008.3 million.
Read it in 10-K Feb 27, 2025 at sec.gov
RemovedRisk Factors
Our relatively limited operating history makes it difficult to evaluate our current business and prospectus and plan for our future growth. We were founded in 2013, with most of our growth occurring in recent years. We have encountered and will continue to encounter significant risks and uncertainties frequently experienced by new and growing companies in heavily regulated and rapidly changing industries, such as determining appropriate investments for our limited resources, scaling our model and technology platform, attracting and retaining members, efficiently navigating and complying with evolving regulations, hiring, integrating, training and retaining skilled personnel, identifying and reaching agreements with reliable healthcare service providers, competing against more established competitors, unforeseen expenses and challenges in forecasting accuracy. Although we have successfully expanded our footprint outside of California and intend to continue to expand into new markets, new plans we provide or new markets we enter may not prove successful. If we are unable to increase our member enrollment, scale our platform, maintain a low cost structure, identify, reach and successfully maintain agreements with reliable healthcare service providers, successfully manage our third-party medical costs or successfully expand the range of services and benefits we offer to members, our revenue and our ability to achieve and sustain profitability would be impaired. Additional risks include our ability to effectively manage growth, process, store, protect and use personal data in compliance with governmental regulation, contractual obligations and other legal obligations related to privacy and security and manage our obligations as a healthcare plan. If our assumptions regarding these and other similar risks and uncertainties, which we use to plan our business, are incorrect or change as we gain more experience operating our business or due to changes in our industry, or if we do not address these challenges successfully, our operating and financial results could differ materially from our expectations and our business could suffer.
Read it in 10-K Feb 27, 2025 at sec.gov
RemovedRisk Factors
•depending upon the nature of the local market, we may not be able to implement our business model in every local market that we enter, which could negatively impact our revenues and financial condition.
Read it in 10-K Feb 27, 2025 at sec.gov
RemovedRisk Factors
by or licensed from third parties, and we may not be able to maintain our relationships with such third parties or enter into similar relationships in the future on reasonable terms or at all.
Read it in 10-K Feb 27, 2025 at sec.gov
RemovedRisk Factors
Most members of our management team have limited experience managing a publicly traded company, interacting with public company investors and complying with the increasingly complex laws pertaining to public companies. Our management team may not successfully or efficiently manage us as a public company that is subject to significant regulatory oversight and reporting obligations under the federal securities laws and the continuous scrutiny of securities analysts and investors. These obligations and constituents require significant attention from our senior management and could divert their attention away from the day-to-day management of our business, which could adversely affect our business, results of operations and financial condition.
Read it in 10-K Feb 27, 2025 at sec.gov
RemovedRisk Factors
The CMS Center for Medicare and Medicaid Innovation (“CMMI”) implemented a direct contracting model, intended to create value-based payment arrangements directly with Direct Contracting Entities (“DCEs”), which is part of CMS’s strategy to drive broader healthcare reform and accelerate the shift from original Medicare toward value-based care models. A key aspect of direct contracting is providing new opportunities for a variety of different DCEs to participate in value-based care arrangements in Medicare fee-for-service. Effective January 1, 2023, CMS replaced the DCE program with the “ACO Realizing Equity, Access, and Community Health Model” or “ACO REACH” model and designated participating entities as Accountable Care Organizations (“ACOs”).
Read it in 10-K Feb 27, 2025 at sec.gov
RemovedRisk Factors
Our participation in the CMMI program began on April 1, 2021 and, as of January 1, 2025, we had approximately 6,650 members in our arrangement with our clinician partners in California and Nevada. Our participation in the ACO REACH program is subject to annual CMS approval, and our contracts are not guaranteed to be renewed in future years. Prior to April 1, 2021, we had no experience participating in CMMI's programs and, as such, our ACO business is in the early stages of development. We are subject to the risks inherent to the launch of any new business, including the risks that we may not generate sufficient returns to justify our investment and that it may take longer or be more costly to achieve the expected benefits from this new program. In particular, we may be unable to achieve risk-like patient economics on original Medicare patients. Moreover, our financial performance under the ACO REACH model may not be similar to our performance under the DCE model.
Read it in 10-K Feb 27, 2025 at sec.gov
RewordedRisk Factors
As a government contractor, we are exposed to risks that may materially adversely affect our business, including the potential loss of CMS contracts, significant changes to the Medicare Advantage and/or Part D programs, potential suspension from participating in the Medicare Advantage program, changes to the risk-adjustment model used to determine the premiums paid to Medicare Advantage plans, changes to provisions for risk sharing under Medicare Part D and risks related to governmental audits and investigations, among others.
Read it in 10-K Feb 27, 2026 at sec.gov
RewordedRisk Factors
We may also suffer loss of reputation, adverse impacts on member and investor confidence and financial loss, and we would be exposed to the risk of governmental investigations or other actions, regulatory or contractual penalties, and other claims and liabilities, including liability under laws and regulations that protect the privacy of member information or other personal information, such as HIPAA. HIPAA as well as other federal and state privacy, data security, consumer protection, biometric information, eavesdropping and wiretapping, electronic communications, and data breach notification laws that permit private rights of action or other civil claims.
Read it in 10-K Feb 27, 2026 at sec.gov
RewordedRisk Factors
Under this model, amounts paid to Medicare Advantage organizations are based, in part, on actuarially determined bids, which include a process whereby our prospective payments are based on our estimated cost of providing standard Medicare-covered benefits to an enrollee with a “national average risk profile.
Read it in 10-K Feb 27, 2026 at sec.gov
RewordedRisk Factors
The On September 23, 2025, the CPPA has released for public comment draft finalized its regulations on risk assessments, cybersecurity assessments, and automated decision-making technologies, which close on February 19, 2025. technologies.
Read it in 10-K Feb 27, 2026 at sec.gov
RewordedRisk Factors
In the 2025 2026 Star ratings, only seven 18 MA-Part D contracts earned a 5-star rating, an increase from seven in 2025 but a significant decrease from 31 in 2024, 2024 and 57 in 2023, and 74 in 2022. 2023.
Read it in 10-K Feb 27, 2026 at sec.gov
RewordedRisk Factors
The Lead Sponsor For example, General Atlantic, which holds approximately 6.7% of our outstanding shares as of December 31, 2025, is entitled, under a registration rights agreement, to require us to register shares owned by it for public sale in the United States.
Read it in 10-K Feb 27, 2026 at sec.gov
RewordedRisk Factors
Accordingly, our plans may receive a lower Star rating and may not be eligible for full level quality bonus payments, which could adversely affect the benefits we can offer, reduce membership and/or reduce profit margins.
Read it in 10-K Feb 27, 2026 at sec.gov
RewordedRisk Factors
A security cybersecurity breach or other breach or privacy violation that leads to disclosure or unauthorized use or modification of, or that prevents access to or otherwise impacts the confidentiality, security, integrity or availability of, member information, including PHI or other PII, PHI, PII or other sensitive information we or our contractors or third-party service providers maintain or otherwise process, could harm our reputation and brand, compel us to comply with breach notification laws, and cause us to incur significant costs for remediation, fines, penalties, providing notification to individuals. individuals and civil claims.
Read it in 10-K Feb 27, 2026 at sec.gov
RewordedRisk Factors
On February 12, 2024, July 3, 2025, the DOJ issued a final rule announcing adjustments to FCA penalties, under which the per claim penalty range was increased to a range from $13,946 $14,308 to $27,894 $28,619 for penalties assessed after February 12, 2024 July 3, 2025 with respect to violations occurring after November 2, 2015.
Read it in 10-K Feb 27, 2026 at sec.gov
RewordedRisk Factors
The Convertible Notes are senior, unsecured obligations of the Company, and interest will be payable semi-annually in arrears at a rate of 4.25% per annum beginning on May 15, 2025.
Read it in 10-K Feb 27, 2026 at sec.gov
RewordedRisk Factors
For example, CCPA, which came into effect on January 1, 2020, requires companies that process personal information on of California residents to make disclosures to consumers about their data collection, use and sharing practices, allow consumers to exercise certain rights with respect to their data, including the right to opt out of certain data sharing with third parties and provides a cause of action for data breaches.
Read it in 10-K Feb 27, 2026 at sec.gov
Quiet changesRisk Factors
In November 2024, CMS announced it had initiated the payment year 2018 RADV audits, and it expects expected to begin issuing the audit findings in mid-calendar year 2026, including instructions on how the overpayments will be collected as part of the audit.
Read it in 10-K Feb 27, 2026 at sec.gov
Quiet changesRisk Factors
Responding to subpoenas, investigations and other lawsuits, claims and legal proceedings as well as defending ourselves in such matters would divert management’s attention and cause us to incur significant legal expense.
Read it in 10-K Feb 27, 2026 at sec.gov
AddedMD&A
We have grown Health Plan Membership, which we define as members enrolled in our health maintenance organization ("HMO") and preferred provider organization ("PPO") contracts (the "Alignment Health Plan"), from approximately 13,000 at inception to 236,300 as of December 31, 2025, representing a 30% compound annual growth rate across 45 markets and 5 states. Our ultimate goal is to bring this differentiated, advocacy-driven healthcare experience to millions of senior consumers in the United States and to become the most trusted senior healthcare brand in the country.
Read it in 10-K Feb 27, 2026 at sec.gov
AddedMD&A
For the 2025 plan year, Alignment offered plans in 45 markets across California (22 markets), North Carolina (16 markets), Nevada (2 markets), Arizona (3 markets) and Texas (2 markets). There are approximately 8.4 million Medicare-eligible seniors in our current markets.
Read it in 10-K Feb 27, 2026 at sec.gov
RemovedMD&A
Our model is based on a flywheel concept, referred to as our “virtuous cycle,” which reflects our unique ability to manage healthcare expenditures while maintaining quality and member satisfaction — a distinct and sustainable competitive advantage.
Read it in 10-K Feb 27, 2025 at sec.gov
RemovedMD&A
To execute upon this concept, we start by ingesting medical and demographic data through our proprietary AVA technology platform. AVA’s predictive algorithms provide unique insights into each member and identify those most at risk of an acute event. Our information-enabled care model is then combined with clinical engagement by our employed clinical teams known as Care Anywhere to improve healthcare outcomes for our members. For example, our high-touch clinical model proactively manages chronic conditions and assists with post-discharge care navigation to reduce unnecessary hospital admissions and readmissions, which in turn improves health outcomes and quality while lowering overall costs. We then reinvest medical cost savings into richer coverage and benefits, which propels growth in revenue and membership while maintaining margin discipline. The strength of our model is further reinforced by delivering a premium member experience. Our concierge and a clinical service hotline is available 24/7 at no additional cost to our members and our state-of-the-art in-house call centers provide us with more consistency and control over member-facing functions.
Read it in 10-K Feb 27, 2025 at sec.gov
RemovedMD&A
Our virtuous cycle, based on the principle of doing well by doing good, is highly repeatable and a core tenet of our ability to continue to expand in existing and new markets in the future. The five-year compounded growth rate through December 31, 2024 of revenue and the number of members enrolled in our HMO and PPO contracts ("Health Plan Membership") is 29% and 31% respectively.
Read it in 10-K Feb 27, 2025 at sec.gov
RemovedMD&A
Today, seniors are confronted with a healthcare landscape that is fragmented across disparate point solutions, tools and vendors, without an accessible, coordinated approach to comprehensive care delivery. Under the traditional Medicare fee-for-service ("FFS") model, seniors receive access to hospital insurance benefits (“Part A”) and outpatient services (“Part B”) directly from CMS. Original Medicare (Part A and B) does not include prescription drug coverage (“Part D”), and most seniors enrolled in original Medicare opt to obtain Part D and other protection for gaps in their coverage by purchasing costly Medicare supplement insurance plans. In contrast, Medicare Advantage plans are direct-to-consumer and provide a single point of care delivery for Part A, Part B and often Part D coverage. Medicare Advantage penetration of the Medicare market is rapidly increasing given the enhanced benefits and coverage that Medicare Advantage plans offer relative to traditional Medicare FFS. In 2024, approximately 54% of the Medicare eligible population, or approximately 33 million seniors, were enrolled in a Medicare Advantage plan. Industry projections have forecasted a continued increase in the Medicare Advantage penetration rate from approximately 54% to approximately 64% by 2033.
Read it in 10-K Feb 27, 2025 at sec.gov
RemovedMD&A
Medicare Advantage allows one entity to influence the entirety of a senior’s healthcare through a singular, direct-to-consumer product. We contract with CMS under the Medicare Advantage program to provide health insurance coverage to Medicare eligible persons under HMO and PPO plans in exchange for a payment per member per month ("PMPM"). The PMPM payment varies based on geography, CMS Star ratings and certain population-specific risk factors. Under these value-based contracts, we assume the economic risk of funding our members’ healthcare, supplemental benefits and related administration costs. By transferring the economic risk to managed care companies like Alignment, CMS has enabled us to focus on proactive, cross-disciplinary care targeted at improving health outcomes and lowering unnecessary healthcare expenditures.
Read it in 10-K Feb 27, 2025 at sec.gov
RemovedMD&A
The Medicare Advantage regulatory framework is designed to reward plans that achieve the triple aim of high-quality care, low costs and better experience. CMS payments to Medicare Advantage plans are allocated in each county or region based on a bidding system. Each plan submits a bid based on its estimated costs per enrollee for services covered under Medicare Parts A and B. Plans that have a low enough cost structure to bid under the benchmark are entitled to rebates, which enable those plans to offer enhanced supplemental benefits and medical coverage to their members, which in turn boosts membership growth and therefore revenue. CMS further measures Medicare Advantage beneficiaries’ clinical outcomes and experience with their health plans and the healthcare system through a Five Star Quality Rating System. Medicare Advantage plans are eligible to receive additional economic incentives based on their Star rating.
Read it in 10-K Feb 27, 2025 at sec.gov
RemovedMD&A
Due to the competitive nature of CMS’s bidding system, only those plans that are able to provide low cost and high-quality outcomes will be able to offer enhanced benefit options, which is critical to achieving sustainable membership and growth on a long-term basis.
Read it in 10-K Feb 27, 2025 at sec.gov
RemovedMD&A
Under the Medicare Advantage system, our members typically enroll with us for a one-year period that can be renewed on an annual basis, resulting in revenue that is principally based on a subscription-like PMPM recurring revenue model. This model provides us with significant visibility into our short-term financial performance, particularly given that the substantial majority of our members continue to choose Alignment after their initial selection year. Further, our HMO and PPO plans covered under Medicare Advantage contracts with CMS are generally renewed for a calendar year term, unless CMS notifies us of its decision not to renew by May 1 of the year in which the contract would end. When carefully managed, this annual renewal process provides a measure of stability and predictability to our short-term revenue streams, allowing us to focus on improving health quality outcomes and lowering healthcare expenditures for our population through enhanced member care on a long-term basis.
Read it in 10-K Feb 27, 2025 at sec.gov
RemovedMD&A
•Achieve Superior Unit Economics: As our senior population ages, their healthcare needs become more frequent and complex. To combat the healthcare cost increases that typically result, we proactively look to (i) connect with our population early in their enrollment with Alignment to assess
Read it in 10-K Feb 27, 2025 at sec.gov
RemovedMD&A
(2) Represents equity-based compensation related to grants made in the applicable year, as well as equity-based compensation related to the timing of the IPO, which includes previously issued stock appreciation rights ("SARs") liability awards, modifications related to transaction vesting units, and grants made in conjunction with the IPO
Read it in 10-K Feb 27, 2025 at sec.gov
RemovedMD&A
Other (income) expenses, net. Other (income) expenses were $(0.1) million and $(0.9) million for the years ended December 31, 2024 and 2023, respectively, a decrease of $0.8 million. The decrease is primarily attributable to the timing of gains and losses related to ROU assets subleased during the respective periods.
Read it in 10-K Feb 27, 2025 at sec.gov
RewordedMD&A
The increase was driven primarily by the growth in Alignment Health Plan membership, which increased 58.6% 25.0% between December 31, 2024 2025 and December 31, 2023. 2024, an increase in unit costs and an increase to our Part D cost sharing due to changes arising from the Inflation Reduction Act.
Read it in 10-K Feb 27, 2026 at sec.gov
RewordedMD&A
The increase in cash used primarily relates to purchases of short-term treasury securities which were $379.1 million reduced investment maturities during the year ended December 31, 2023 2025 compared to $82.2 million during the year ended December 31, 2024, a decrease of 296.9 million. 2024.
Read it in 10-K Feb 27, 2026 at sec.gov
RewordedMD&A
Interest expense 15,799 23,547 21,231 Depreciation and amortization (1) 30,482 27,062 21,668 Income tax expense (benefit) 20 21 (22) Equity-based compensation (2) 62,082 71,132 66,835 Acquisition expenses (3) — 26 977 Litigation costs (4) 2,357 2,069 2,298 (Gain) loss on ROU assets (5) — 143 (289) Gain on sale of property and equipment (72) (9) — Restructuring costs (6) — 2,363 — Loss on extinguishment of debt — 3,020 — Adjusted EBITDA $ 109,944 $ 1,339 $ (35,319)
Read it in 10-K Feb 27, 2026 at sec.gov
RewordedMD&A
Medical expenses 89 89 87.6 89.0 Selling, general general, and administrative expenses 14 17 11.2 13.7 Depreciation and amortization 1 1 0.8 1.0 Total expenses 104 107 Loss 99.6 103.7 Income (loss) from operations (4) (7) 0.4 (3.7) Other expenses:
Read it in 10-K Feb 27, 2026 at sec.gov
RewordedMD&A
Interest expense 1 1 0.4 0.9 Other (income) expenses, income, net — — Loss on extinguishment of debt — — 0.1 Total other expenses 1 1 0.4 1.0 Loss before income taxes (5) (8) — (4.7) Provision for income taxes tax expense — — Net loss (5) (8) — (4.7) Less:
Read it in 10-K Feb 27, 2026 at sec.gov
RewordedMD&A
According As of January 1, 2026, we have approximately 275,300 Health Plan Members, which, according to CMS data, our approximately 209,900 Health Plan Members represent only 5% 6% market share of Medicare Advantage enrollees in our markets.
Read it in 10-K Feb 27, 2026 at sec.gov
RewordedMD&A
Overall, medical expenses for the year ended December 31, 2024 2025 grew at a slightly higher lower rate than earned premium revenues compared to the year ended December 31, 2023, 2024, primarily due to 2024 having a higher percentage of new members relative to returning members, richer member benefits and increases members in unit costs. 2024 compared to 2025.
Read it in 10-K Feb 27, 2026 at sec.gov
RewordedMD&A
Interest expense 15,799 23,547 21,231 Other (income) expenses, income, net (89) (72) (853) Loss on extinguishment of debt — 3,020 — Total other expenses 15,710 26,495 20,378 Loss before income taxes (958) (128,050) (148,195) Provision for income tax expense (benefit) 20 21 (22) Net loss $ (978) $ (128,071) $ (148,173) Less:
Read it in 10-K Feb 27, 2026 at sec.gov
RewordedMD&A
Year Ended December 31, (dollars in thousands) 2025 2024 2023 Net cash provided by (used in) operating activities $ 139,927 $ 34,770 $ (59,187) Net cash provided by (used in) investing activities (14,974) 39,191 (147,263) Net cash provided by financing activities 18,041 156,028 105 Net change in cash 142,994 229,989 (206,345) Cash, cash equivalents and restricted cash at beginning of period 434,943 204,954 411,299 Cash, cash equivalents and restricted cash at end of period $ 577,937 $ 434,943 $ 204,954
Read it in 10-K Feb 27, 2026 at sec.gov
RewordedMD&A
AVA enables AVA’s data insights, combined with the clinical control of our care model, enable us to personalize and manage our member relationships, care quality and experience, quality, and to coordinate and manage risk with our provider partners.
Read it in 10-K Feb 27, 2026 at sec.gov
RewordedMD&A
We recognize premium or capitation revenue for providing this insurance coverage in the month that members are entitled to receive healthcare services. health care services and any premium or capitation collected in advance is deferred.
Read it in 10-K Feb 27, 2026 at sec.gov
RewordedMD&A
The increase is mainly attributable to an increase in the interest rate of our interest earning cash balances. balances and current investments and an increase in revenue from services provided to third-party providers.
Read it in 10-K Feb 27, 2026 at sec.gov

Sources

The two latest 10-Ks on EDGAR, section by section. Each change links to the text at sec.gov.

Also

New risk factors: paragraphs with nothing like them last year, quoted in full.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ALHC/export.csv") into a cell.

Next:Related parties
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.